Korsana Biosciences, Inc. Common Stock
KRSA
14 hedge funds and large institutions have $2.7M invested in Korsana Biosciences, Inc. Common Stock in 2024 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 5 reducing their positions, and 2 closing their positions.
12% more capital invested
Capital invested by funds: $2.41M → $2.7M (+$285K)
0.33% less ownership
Funds ownership: 38.81% → 38.47% (-0.33%)
7% less funds holding
Funds holding: 15 → 14 (-1)
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
50% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 2
80% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 5
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Bank of America
Charlotte,
North Carolina
|
+$3 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AG
Artal Group
Luxembourg
|
-$271K |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
-$1.59K |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$1.08K |
| 4 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$1K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
-$162 |
KRSA Hedge Fund Activity: Q3 2024 in Review
14 of the 6,979 institutional investors tracked by Wall St. Rank reported a position in Korsana Biosciences, Inc. Common Stock (KRSA) for Q3 2024, worth a combined $2.7M — up 12% from $2.41M a quarter earlier.
Sellers outnumbered buyers: 2 funds closed out of KRSA and 1 opened new positions — a net loss of 1 holder — while 5 trimmed existing stakes and 1 added.
The largest buyer was Bank of America, adding an estimated $3. The largest seller was Artal Group, exiting entirely with an estimated $271K sold.
- 14 institutional investors held Korsana Biosciences, Inc. Common Stock (KRSA) as of Q3 2024, down from 15 in Q2 2024.
- Funds reported $2.7M of Korsana Biosciences, Inc. Common Stock stock for Q3 2024, up 12% quarter-over-quarter.
- 1 fund opened new Korsana Biosciences, Inc. Common Stock positions in Q3 2024 and 2 closed out, a net change of -1 holder.
- The largest Korsana Biosciences, Inc. Common Stock buyer in Q3 2024 was Bank of America, an estimated $3 added.
- The largest Korsana Biosciences, Inc. Common Stock seller in Q3 2024 was Artal Group, an estimated $271K sold.
Based on aggregated 13F filings for Q3 2024.